Skip to main content
. 2024 Jul 5;34(7):324–330. doi: 10.2188/jea.JE20230210

Table 1. Characteristics of the study participants (n = 74,240).

  Number (%)
Maternal history of allergy
 Yes 35,841 (48.5)
 No 38,057 (51.5)
Maternal age at pregnancy, years
 <25 8,114 (10.9)
 ≥25 and <30 21,356 (28.8)
 ≥30 and <35 26,294 (35.4)
 ≥35 18,476 (24.9)
Household income, million JPY/year
 <4 26,353 (35.5)
 ≥4 to <6 35,045 (47.2)
 ≥6 7,873 (10.6)
 Unknown 4,969 (6.7)
Mode of delivery
 Caesarean section 14,508 (19.6)
 Vaginal 59,417 (80.4)
Birth weight, g
 <2,500 6,621 (8.9)
 ≥2,500 67,448 (91.1)
Child’s sex
 Male 37,974 (51.2)
 Female 36,266 (48.9)
Older siblings
 Yes 39,456 (53.4)
 No 34,442 (46.6)
Duration of exclusive breast-feeding
 <6 months 44,215 (59.6)
 At least 6 months 30,025 (40.4)
Passive smoking during pregnancy
 Yes 14,813 (20.2)
 No 58,491 (79.8)
Doctor diagnosed allergy
 Infantile eczema 3,086 (4.2)
Mother’s peanut intake during pregnancy
 At least once a week 3,688 (5.1)
 1–3 times a month 13,753 (19.0)
 Less than once a month 55,095 (76.0)
Peanut introduction status at age 1 year
 ≤6 months 79 (0.1)
 7–8 months 440 (0.6)
 9–10 months 1,154 (1.6)
 11–12 months 1,693 (2.3)
 Intake after 13 months 367 (0.5)
 Not ingested 70,507 (95.0)

JPY, Japanese yen.